In its latest
report, Transparency Market Research, a U.S.-based market
intelligence firm states that the global orthobiologics market is
estimated to be worth $ 5,519.9 million by the end of 2019. The
report, titled ‘Orthobiologics Market - Global Industry Analysis,
Size, Share, Growth, Trends and Forecast, 2013 - 2019,’also states
that the market for orthobiologics across the world was worth
$3,745.6 million in 2012 and will grow at a compound annual growth
rate (CAGR) of 5.9% in the forecast period.
Browse the full
Orthobiologics Market Report at
http://www.transparencymarketresearch.com/orthobiologics-market.html
Nearly half of the
population aged 50 years and above is afflicted by bone and joint
disorders, and this number is expected to almost double by the year
2020. This has and will continue to increase the demand for
orthobiologics. Other factors which have fueled the growth of the
orthobiologics market are technological advances, declining usage of
allografts and autografts in orthopedic procedures, change in
lifestyle, increase in obesity cases, and rise in sports activities
and sports injuries.
However, the strict
regulatory requirements and lack of reimbursement are expected to
restrain market growth.
According to the
report, the market for orthobiologics can be segmented on the basis
of products, applications, and geography.
Product: The various
product types of orthobiologics include machined bones, allografts,
bone morphogenetic proteins (BMPS), demineralized bone matrix (DBM),
stem cell therapy, synthetic bone substitutes, and
viscosupplementation.
Applications: The
numerous applications of orthobiologics are trauma, spinal fusion,
and reconstructive surgery.
Geography: The
orthobiologics industry is classified into four main regions - North
America, Europe, Asia-Pacific and Rest of the World.
Among all the
products, viscosupplementation make up the largest share in the
market. It is comparatively more powerful and effective as a
painkiller than other pain relievers and with the number of knee
treatments on the rise, demand for viscosupplementation has gone up.
Bone morphogenetic proteins (BMPs) follow next in terms of market
share, although its growth is likely to decline during the forecast
period of 2013-2019 owing to its falling sales of INFUSE – a
Medtronic product with severe side effects. Faster recovery, lower
costs and no risk of transmission will enable stem cell based
products and synthetic bone substitutes gain significant growth in
future.
Browse the full
Press Release Report :
http://www.transparencymarketresearch.com/pressrelease/orthobiologics-market.htm
In terms of
location, North America and Europe both lead the global market due to
increasing popularity and demand for minimally invasive surgeries
such as growth factor treatment and bone grafting. Asia-Pacific,
however, is expected to witness the fastest growth rate between 2013
and 2019.
The TMR report
profiles some of the major players and their contribution to the
global orthobiologics market. The leading companies include Stryker
Corporation, Medtronic, Inc., Wright Medical Technology, Inc.,
Orthofix, Inc., NuVasive, Inc., and DePuySythes.
Request a Brochure
of this Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1747
About Us
Transparency Market
Research is a global market intelligence company, providing global
business information reports and services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking
insight for thousands of decision makers. We are privileged with
highly experienced team of Analysts, Researchers, and Consultants,
who use proprietary data sources and various tools and techniques to
gather, and analyze information.
Our data repository
is continuously updated and revised by a team of research experts, so
that it always reflects the latest trends and information. With a
broad research and analysis capability, Transparency Market Research
employs rigorous primary and secondary research techniques in
developing distinctive data sets and research material for business
reports.
No comments:
Post a Comment